Engineering heavy chain antibody-drug conjugates against solid tumors for a one-shot kill

被引：0
|
作者：
Liu, Xue [1 ,2 ]
Ning, Wenjing [1 ,2 ]
Wang, Lei [3 ,4 ]
Liu, Han [1 ,2 ]
Zeng, Hongye [1 ,2 ]
Qin, Xiaojing [1 ,2 ]
Chen, Yuanzhi [1 ,2 ]
Chen, Fentian [1 ,2 ]
Xu, Lin [1 ,2 ]
Zhao, Yang [3 ,4 ]
Chen, Xiaoqing [1 ,2 ]
Tang, Jixian [1 ,2 ]
Ren, Yunlong [1 ,2 ]
Yan, Xiaowen [3 ,4 ,5 ]
Luo, Wenxin [1 ,2 ]
Xia, Ningshao [1 ,2 ]
机构：
[1] Xiamen Univ, Sch Publ Hlth, State Key Lab Vaccines Infect Dis, Xiang Biomed Lab, Xiamen 361102, Fujian, Peoples R China
[2] Xiamen Univ, Chinese Acad Med Sci, Natl Inst Diagnost & Vaccine Dev Infect Dis, State Key Lab Mol Vaccinol & Mol Diagnost,Natl Inn, Xiamen, Fujian, Peoples R China
[3] Xiamen Univ, Coll Chem & Chem Engn, Dept Chem, Xiamen 361005, Fujian, Peoples R China
[4] Xiamen Univ, MOE Key Lab Spectrochem Anal & Instrumentat, Xiamen 361005, Fujian, Peoples R China
[5] Innovat Lab Sci & Technol Energy Mat Fujian Prov I, Xiamen, Fujian, Peoples R China
来源：
CANCER COMMUNICATIONS | 2024年 / 44卷 / 12期
基金：
中国国家自然科学基金;
关键词：
NANOBODIES;
D O I：
10.1002/cac2.12616
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1444 / 1448
页数：5
相关论文
共 50 条
  • [1] Biomarkers for Antibody-Drug Conjugates in Solid Tumors
    Katrini, Jalissa
    Boldrini, Laura
    Santoro, Celeste
    Valenza, Carmine
    Trapani, Dario
    Curigliano, Giuseppe
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (04) : 436 - 446
  • [2] Antibody-drug conjugates in solid tumors: a new frontier
    Jaime-Casas, Salvador
    Barragan-Carrillo, Regina
    Tripathi, Abhishek
    CURRENT OPINION IN ONCOLOGY, 2024, 36 (05) : 421 - 429
  • [3] Antibody-drug conjugates in solid tumors: a look into novel targets
    Criscitiello, Carmen
    Morganti, Stefania
    Curigliano, Giuseppe
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [4] The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
    Qing Wei
    Peijing Li
    Teng Yang
    Jiayu Zhu
    Lu Sun
    Ziwen Zhang
    Lu Wang
    Xuefei Tian
    Jiahui Chen
    Can Hu
    Junli Xue
    Letao Ma
    Takaya Shimura
    Jianmin Fang
    Jieer Ying
    Peng Guo
    Xiangdong Cheng
    Journal of Hematology & Oncology, 17
  • [5] Antibody-drug conjugates in solid tumors; new strategy for cancer therapy
    Takakura, Toshiaki
    Shimizu, Toshio
    Yamamoto, Nobuyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (08) : 837 - 846
  • [6] The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
    Wei, Qing
    Li, Peijing
    Yang, Teng
    Zhu, Jiayu
    Sun, Lu
    Zhang, Ziwen
    Wang, Lu
    Tian, Xuefei
    Chen, Jiahui
    Hu, Can
    Xue, Junli
    Ma, Letao
    Shimura, Takaya
    Fang, Jianmin
    Ying, Jieer
    Guo, Peng
    Cheng, Xiangdong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)
  • [7] Leveraging TROP2 Antibody-Drug Conjugates in Solid Tumors
    Nelson, Blessie Elizabeth
    Meric-Bernstam, Funda
    ANNUAL REVIEW OF MEDICINE, 2024, 75 : 31 - 48
  • [8] Antibody-Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review
    Lambert, John M.
    Morris, Charles Q.
    ADVANCES IN THERAPY, 2017, 34 (05) : 1015 - 1035
  • [9] Antibody engineering for improving efficacy of antibody-drug conjugates
    Tsumura, Ryo
    Anzai, Takahiro
    Takashima, Hiroki
    Koga, Yoshikatsu
    Yasunaga, Masahiro
    CANCER SCIENCE, 2022, 113 : 1700 - 1700
  • [10] Antibody-Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest Developments
    Nagayama, Aiko
    Ellisen, Leif W.
    Chabner, Bruce
    Bardia, Aditya
    TARGETED ONCOLOGY, 2017, 12 (06) : 719 - 739
12345